Your browser doesn't support javascript.
loading
Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax.
Liu, Hongcai; Hussain, Zubair; Xie, Qingqing; Yan, Xueying; Zeng, Chenxing; Zhou, Gan; Cao, Shan.
Afiliación
  • Liu H; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha, 410078, PR China; Engineering Research Cen
  • Hussain Z; Department of Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
  • Xie Q; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha, 410078, PR China; Engineering Research Cen
  • Yan X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha, 410078, PR China; Engineering Research Cen
  • Zeng C; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha, 410078, PR China; Engineering Research Cen
  • Zhou G; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha, 410078, PR China; Engineering Research Cen
  • Cao S; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha, 410078, PR China; Engineering Research Cen
Exp Cell Res ; 417(2): 113192, 2022 08 15.
Article en En | MEDLINE | ID: mdl-35568072
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Exp Cell Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Exp Cell Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos